%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue
of 2019 was THB 232.72 million, an increase of THB 60.42 million or 35.06% when comparing with the same period of last year. Earnings per share increased from THB 0.16 per share to THB 0.21 per share
MB and increase from gains on remeasurements of defined benefit plans - net of tax amounted THB 2.4 MB. The Company has a road map for sustainable growth. The Company has planned for sufficient in
percent in Q2/2018). The increase of gross profit was the result of low overhead cost due to high production volume and the higher in sales. Selling Expenses The Company and its subsidiaries had the
nine-month period ended September 30, 2018 and the nine-month period ended September 30, 2019, respectively. The figures represent a period-on-period increase of 65.46% due mainly to an increasing in
profit of 3,609.03 million baht while the same period last year the Company and its subsidiaries recorded net profit of 2,630.93 million baht, increase of 978.10 million baht or increase by 37.18% because
, increased by THB1.91 million from the same period of last year, or about 27.22% increase, and recorded net loss of THB164.23 million, compared to the net loss of THB35.28 million from the same period of last
Thailand Overview of the operating result for the second quarter of 2019 ▪ The company’s total net income was Baht 192.49 million, representing an increase of 76.9% over the same period last year and revenue
-time employment to support the growth of business and in the increase of salary in according to the Group’s human resources policy, and (2) other administrative expenses ranging from office expenses
bundling to increase average revenue per household (ARPH). • Enterprise business is anticipated to continue delivering double digit growth – With strong demand for digitalizing business operation under new